OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.
Our Stocks to Watch today include Monogram Energy Inc. (OTC: MGRN), CelebDirect (OTC: CELI), Lantis Laser Inc. (OTC: LLSR), International Building Technologies Group Inc. (OTCBB: INBG), SGX Pharmaceuticals (NASDAQ: SGXP), CruiseCam International Inc. (OTC: CCMJ)
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/
MONOGRAM ENERGY INCORPORATED (OTC: MGRN)
Detailed Quote: www.otcpicks.com/quotes/MGRN.php
Company Profile:
www.otcpicks.com/monogram-energy/monogram-energy.htm
Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.
CELEBDIRECT INCORPORATED (OTC: CELI)
Detailed Quote: http://www.otcpicks.com/quotes/CELI.php
Company Profile: http://www.otcpicks.com/celebdirect/celebdirect-2.htm
CelebDirect's primary business is that of a direct response celebrity incubator and has two divisions which are direct response marketing and Celebrity placement / franchise opportunities. CelebDirect brings to the market unique and innovative products via direct to market strategies such as infomercials, advertorials and other associated advertising vehicles to expeditiously, economically and broadly market products throughout North American as well as a global basis. CelebDirect has a number of consumer-oriented products it is evaluating and others it is currently bringing to market.
LANTIS LASER INCORPORATED (OTC: LLSR)
Detailed Quote: http://www.otcpicks.com/quotes/LLSR.php
Company Profile: http://www.otcpicks.com/lantis-laser/lantis-laser-2.htm
Lantis Laser was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System™ in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); LightLab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser, visit http://www.lantislaser.com/.
INTERNATIONAL BUILDING TECHNOLOGIES (OTCBB: INBG)
"Up 263.64% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/XKEM.php
International Building Technologies Group, Inc. engages in the manufacture and sale of light weight building panels used in construction worldwide. It also provides customers with architectural design, panel supply, installation supervision, engineering, training, and technical support. The company's building panels have applications in residential homes, schools, high rise buildings, churches, condominiums, mining shafts, hospitals, fences and walls, vacation lodges, medical care centers, and community buildings. International Building Technologies Group is based in Alameda, California with an additional office in Shanghai, the People's Republic of China.
SGX PHARMACEUTICALS INCORPORATED (NASDAQ: SGXP)
"Up 121.18% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SGXP.php
SGX Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of therapeutics for addressing unmet medical needs in oncology. The company's product pipeline includes drug candidates from its FAST drug discovery platform, which uses X-ray crystallography and complementary biophysical and biochemical methods, combined with medicinal and computational chemistry. Its drug development programs target the c-MET receptor tyrosine kinase (MET), an enzyme implicated in an array of cancers; and the BCR-ABL tyrosine kinase enzyme for the treatment of chronic myelogenous leukemia (CML), a bone marrow cancer. Under the MET development program, the company develops SGX523, which is in Phase I clinical development studies for solid tumor indications; and SGX126, a preclinical development product for solid tumors indications. Under the BCR-ABL Development Program, SGX Pharmaceuticals develops SGX393, an oral therapy for the second-line treatment of CML, which is in preclinical development studies. Its drug discovery technologies are also applied to a portfolio of oncology targets, including JAK2, a non-receptor tyrosine kinase involved in cytokine-induced signaling and growth regulation, survival, and differentiation of cells; RAS, a protein that regulates cell growth; and three other tyrosine kinases. The company has a license and collaboration agreement with Novartis Institutes for Biomedical Research, Inc., Cystic Fibrosis Foundation Therapeutics, Inc., National Institutes of Health, and Eli Lilly & Company. SGX Pharmaceuticals, formerly known as Structural GenomiX, Inc., was founded in 1998 and is headquartered in San Diego, California.
CRUISECAM INTERNATIONAL INCORPORATED (OTC: CCMJ)
"Up 66.67% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CCMJ.php
CruiseCam International, Inc., through its two operating subsidiaries, develops and markets integrated, "in-car" camera mount and recording systems for law enforcement, consumer, commercial and transportation applications, as well as for competition racing cars. The Company's patented technology and industry-first "Cruisecam" offering have been developed since 1996, and are distributed nationwide. For more information, visit http://www.cruisecam.com/.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has received seventy thousand free trading shares from a non-controlling third party (Dana Alex) for CELI advertising and promotional services. OTCPicks.com has been compensated two hundred thousand restricted 144 shares from a third party for LLSR advertising and promotional services. OTCPicks.com has received fifty thousand free trading shares from a non-controlling third party (Microcap Management) for MGRN advertising and promotional services.
